HAP Trading’s Iovance Biotherapeutics IOVA Stock Holding History

HAP Trading’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,264	Closed	-$352K	–	2686
2021 Q3	$352K	Buy	+14,264	New	+$336K	0.01%	800

Other funds holding IOVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HAP Trading's IOVA Position: Q4 2021 in Review

HAP Trading sold out of Iovance Biotherapeutics (IOVA) in Q4 2021, closing a stake of 14,264 shares — an estimated $352K sold.

HAP Trading first reported a position in IOVA in Q3 2021 and held it in 1 quarter. The position peaked at $352K in Q3 2021. 246 funds tracked by Wall St. Rank hold IOVA as of Q4 2021.

HAP Trading reported no remaining Iovance Biotherapeutics position as of Q4 2021 after selling out during the quarter.
HAP Trading sold 14,264 Iovance Biotherapeutics shares in Q4 2021, an estimated $352K.
HAP Trading first reported a position in Iovance Biotherapeutics in Q3 2021 and held it in 1 quarter.
HAP Trading's Iovance Biotherapeutics position peaked at $352K in Q3 2021.
246 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.